Albendazole as an alternative therapeutic agent for childhood giardiasis in Turkey

Simple item page
dc.contributor.authorYereli K.
dc.contributor.authorBalcioĝlu I.C.
dc.contributor.authorErtan P.
dc.contributor.authorLimoncu E.
dc.contributor.authorOnaĝ A.
dc.date.accessioned2024-07-22T08:24:29Z
dc.date.available2024-07-22T08:24:29Z
dc.date.issued2004
dc.description.abstractThe efficacy of albendazole for the treatment of giardiasis has been indicated by previous in-vitro and in-vivo studies. In order to compare the therapeutic efficacy of albendazole and metronidazole, 107 Giardia-positive children (aged 3-15 years), diagnosed by three consecutive positive stool examinations, were enrolled in the study. Of these children, 52 were given a single daily dose of albendazole 10 mg/kg for 5 days, and 55 were given metronidazole 20 mg/kg daily in three doses for 7 days. Parasite eradication was achieved in 47 (90.4%) of 52 children treated with albendazole and 49 (89.1%) of 55 children treated with metronidazole (p > 0.05). These results suggest that albendazole is an effective treatment option for childhood giardiasis. © 2004 Copyright by the European Society of Clinical Microbiology and Infectious Diseases.
dc.identifier.DOI-ID10.1111/j.1198-743X.2004.00829.x
dc.identifier.issn1198743X
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/19978
dc.language.isoEnglish
dc.publisherBlackwell Publishing Ltd
dc.rightsAll Open Access; Hybrid Gold Open Access
dc.subjectGiardia
dc.subjectGiardia intestinalis
dc.subjectalbendazole
dc.subjectbenzimidazole derivative
dc.subjectmepacrine
dc.subjectmetronidazole
dc.subjectadolescent
dc.subjectarticle
dc.subjectchild
dc.subjectchildhood disease
dc.subjectcontrolled study
dc.subjectdrug dose regimen
dc.subjectdrug efficacy
dc.subjectdrug safety
dc.subjecteradication therapy
dc.subjectfeces analysis
dc.subjectGiardia lamblia
dc.subjectgiardiasis
dc.subjecthuman
dc.subjectin vitro study
dc.subjectin vivo study
dc.subjectmajor clinical study
dc.subjectpriority journal
dc.subjectsingle drug dose
dc.subjectstatistical significance
dc.subjectTurkey (republic)
dc.titleAlbendazole as an alternative therapeutic agent for childhood giardiasis in Turkey
dc.typeArticle

Files

Collections

Scopus Koleksiyonu